Xygrel 60mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Ticagrelor (60mg)
Overview Xygrel 60mg Tablet
Brilinta 60mg tablets are classified as antiplatelet agents, effectively hindering the development of dangerous blood clots within blood vessels. This action safeguards against heart attacks and strokes in individuals with pre-existing heart conditions. Brilinta 60mg tablets are also indicated for patients who have recently experienced a heart attack, intense chest pain associated with the heart (unstable angina), or have undergone coronary stenting. Its use diminishes the risk of subsequent cardiac events, including further heart attacks, strokes, or clot formation within stents. Concomitant use of aspirin, another antiplatelet medication, is typically prescribed by your physician. Brilinta 60mg tablets can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even in the absence of symptoms, as discontinuation raises the risk of recurrent heart attacks or strokes. The most frequent adverse effect is bleeding; wounds may bleed more profusely and for extended periods. While usually mild and self-resolving, persistent or worsening bleeding should be reported to your doctor. Some patients experience mild shortness of breath, generally subsiding with continued therapy; however, any persistent or worsening shortness of breath should also be communicated to your physician. Brilinta 60mg tablets are contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your physician prior to commencing treatment.
Uses of Xygrel 60mg Tablet
Avert cardiac arrest and cerebrovascular accident.
Major Benefits of Xygrel 60mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Xygrel 60mg Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Xygrel 60mg Tablet:
- Bleeding
- Breathlessness
How to use Xygrel 60mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Xygrel 60mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Xygrel 60mg Tablet works:
Brilinta 60mg tablets are an antithrombotic agent that inhibits platelet aggregation, thus reducing the risk of dangerous blood clots and subsequently lowering the likelihood of a heart attack or stroke.
SAFETY ADVICE
AlcoholCAUTION
Use of Xygrel 60mg Tablets with alcohol requires medical supervision. Consult your physician before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Xygrel 60mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Xygrel 60mg Tablet use while breastfeeding is absent. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Xygrel 60mg tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Xygrel 60mg tablets without requiring a dosage change. Data on Xygrel 60mg tablet use in individuals undergoing renal dialysis is scarce.
LiverCAUTION
Patients with liver impairment should use Xygrel 60mg tablets cautiously, potentially requiring dose modification. Consult a physician before use. Xygrel 60mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Xygrel 60mg Tablet :
Should you forget to take your Xygrel 60mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Xygrel 60mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |





